Point72 Asset Management, L.P.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1603466
STAMFORD, CT
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$57,384,410
-$32,823,566 QoQ
Shares Held
2,577,916
-23.7% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2026CallValue
$304,962
CallShares
13,700
PutValue
$304,962
PutShares
13,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. ACAD ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in ACAD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $304,962 | 13,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $304,962 | 13,700 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $57,384,410 | 2,577,916 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $90,207,976 | 3,377,311 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $31,718,858 | 1,486,357 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $68,431,062 | 3,172,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $77,200,223 | 4,647,816 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $40,935,455 | 2,230,815 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $1,657,500 | 102,000 | Call | Defined | 2024-09-16 | |
| 2024-06-30 | $60,289,775 | 3,710,140 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $1,664,100 | 90,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $14,361,183 | 776,700 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,299,413 | 392,827 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,055,400 | 50,643 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,361,627 | 891,926 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,411,902 | 659,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,765,128 | 1,115,900 | Shares | Defined | 2023-05-15 | |
| 2021-03-31 | $5,131,620 | 198,900 | Call | Defined | 2021-05-17 | |
| 2020-12-31 | $8,933,166 | 167,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $23,850,543 | 578,195 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $9,621,779 | 198,510 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||